Page 5 - World Health Organization

Covid-19 deaths in Europe could reach 2.2 mn by spring 2022: WHO

WHO Regional Office for Europe said on Wednesday that the cumulative reported Covid-19 deaths across the continent are projected to reach over 2.2 million by spring next year, based on current trends.

China's Wuhan market reemerges as likely covid origin in new chronology

Scientists have yet to determine the origins of SARS-CoV-2, with debate about its genesis has coalesced around two competing ideas.

Europe is only region with increasing coronavirus deaths, says WHO

The World Health Organisation says coronavirus deaths in Europe rose by 5 per cent in the last week, making it the only region in the world where COVID-19 mortality increased. The UN health agency said confirmed cases jumped 6 per cent jump globally, driven by increases in the Americas, Europe and Asia. In its weekly report on the pandemic issued late Tuesday, WHO said COVID-19 deaths in all regions other than Europe remained stable or declined, and totaled 50,000 worldwide last week. Of the 3.3 million new infections reported, 2.1 million came from Europe. It was the seventh consecutive week that COVID-19 cases continued to mount across the 61 countries WHO counts in its European region, which stretches through Russia to central Asia. While about 60 per cent of people in Western Europe are fully immunized against COVID-19, only about half as many are vaccinated in the eastern part of the continent, where officials struggle to overcome widespread vaccine hesitancy. WHO said infect

Looking beyond AQI: How Indian cities compare with others worldwide

Indian cities' air pollution was even higher than the WHO set standards and worse than most cities even on the days pollution was at its lowest

Covid pandemic significantly impacted climate change efforts: WHO

Covid-19 pandemic has slowed down climate change efforts by various countries, according to the 2021 WHO health and climate change global survey report released on Monday

Novavax files for emergency use listing of Covid-19 vaccine with WHO

Biotechnology firm Novavax Inc said it has completed the rolling submission for the emergency use listing (EUL) of its COVID-19 vaccine candidate to the World Health Organization (WHO). Earlier on Monday, Novavax and its partner Serum Institute of India (SII) had said that they had received the first emergency use authorisation (EUA) for COVID-19 vaccine in Indonesia. "The company has now completed the submission to World Health Organization (WHO) of all modules required for the regulatory evaluation of NVX-CoV2373, the company's recombinant nanoparticle protein-based COVID-19 vaccine with Matrix-M adjuvant," Novavax Inc said in a statement on Thursday. The chemistry, manufacturing and controls module submitted to WHO, as well as other regulatory agencies worldwide, leverages Novavax' manufacturing partnership with the SII, the world's largest vaccine manufacturer by volume, it added. Novavax will make further submissions to enable vaccine supply from additional manufacturing sites

Top headlines: States slash VAT on fuel; WHO sees Covid rebound in Europe

Business Standard brings you the top stories from today

Bharat Biotech's Covaxin set to go global after WHO gives it a booster

Becomes sixth vaccine to receive validation; move will ease foreign travel for those who got jab

A big boost

Covaxin gets the stamp of international legitimacy

Live updates: TMC sweeps assembly bypolls, BJP keeps MP, Cong wins in HP

Three Lok Sabha and 29 Assembly constituencies held by-elections on October 30.

G20 agrees to strengthen WHO on EUAs for Covid jabs: Piyush Goyal

Prime Minister Modi had told G20 leaders on Saturday that India is ready to produce over 5 billion Covid vaccine doses by the end of next year to help the world in the fight against the pandemic

WHO director-general Ghebreyesus runs unopposed for 2nd five-year term

Tedros, an Ethiopian national who is the first African to head WHO, has overseen the agency's complex response to the Covid-19 pandemic

We trust India, Bharat Bio submitting data on EUL of Covaxin regularly: WHO

WHO official says the organisation is in touch with Bharat Biotech and has 'daily conversations' 'clarifying what additional data needs' to be submitted

No nod for Bharat Bio's Covaxin yet, WHO seeks 'additional clarifications'

The technical advisory group will now meet on November 3 for a final assessment.

WHO chief congratulates PM, health workers as India hits vaccine milestone

WHO Director-General Tedros Adhanom Ghebreyesus congratulated Prime Minister Narendra Modi, the scientists, health workers and citizens of India for equitable vaccine distribution

India registers 18% decrease in numbers of new Covid-19 cases: WHO

India also reported a 13 per cent decline in the number of deaths during the week of October 11 to 17, the WHO has said

WHO expecting more info from Bharat Biotech for Covaxin approval

Covaxin is one of the three approved vaccines that have been used in India for the country's vaccination drive for adults.

Top headlines: NCLT setback for Amazon; WHO seeks more info for Covaxin

Business Standard brings you the top stories from today

Covid-19 LIVE: Kerala reports 10,691 new infections, 85 deaths in 24 hrs

Coronavirus live updates: India restricts export of certain syringes used for Covid-19 vaccination; Vietnam plans to start vaccinating children aged from 12 to 17.

Covid LIVE: Kerala sees below 10,000 new cases after 4 days

Coronavirus live updates: Indians asked to watch their 'October, November, December' and put on facemasks on trains.